U.S. Market for Psoriasis Cream and Medication 2009

Content

• Executive Summary
  • 1.1 Psoriasis Treatment Market
  • 1.2 Psoriasis Treatment Utilization
  • 1.3 Competitive Analysis
• Research Methodology
  • 2.1 Research Scope
  • 2.2 Idata's 9-Step Methodology
  • 2.2.1 Step 1: Project Initiation & Team Selection
  • 2.2.2 Step 2: Prepare Data Systems and Perform Secondary Research
  • 2.2.3 Step 3: Preparation for Interviews & Questionnaire Design
  • 2.2.4 Step 4: Performing Primary Research
  • 2.2.5 Step 5: Research Analysis: Establishing Baseline Estimates
  • 2.2.6 Step 6: Market Forecast and Analysis
  • 2.2.7 Step 7: Identify Strategic Opportunities
  • 2.2.8 Step 8: Final Review and Market Release
  • 2.2.9 Step 9: Customer Feedback and Market Monitoring
• Psoriasis Cream and Medication Market
  • 3.1 Introduction
  • 3.1.1 Status of Pharmacotherapy in Psoriasis
  • 3.1.1.1 Topical Treatments
  • 3.1.1.2 Non-Biologic Systemic Treatments
  • 3.1.1.3 Biologic Systemic Treatments
  • 3.2 Market Overview
  • 3.2.1 Psoriasis Patient Population
  • 3.2.1.1 Number of Treatments per Patient
  • 3.2.2 Psoriasis Treatment Utilization
  • 3.2.3 Psoriasis Treatment Prices
  • 3.3 Market Analysis and Forecast
  • 3.3.1 Combined Market
  • 3.3.2 Market for Topical Psoriasis Treatments
  • 3.3.3 Market for Biologic Treatments
  • 3.3.4 Market for Non-Biologic Systemic Treatments
  • 3.4 Market Drivers and Limiters
  • 3.4.1 Market Drivers
  • 3.4.2 Market Limiters
  • 3.5 Competitive Analysis
  • 3.5.1 Total Psoriasis Treatment Competitive Analysis
  • 3.5.2 Topical Treatment Competitive Analysis
  • 3.5.3 Biologic Treatment Competitive Analysis
  • 3.5.4 Non-Biologic Systemic Treatment Competitive Analysis
• Abbreviations
• List of Figures
  • Executive Summary
  • Research Methodology
  • Psoriasis Cream and Medication Market
    • Figure 3-1: Psoriasis Patient Population, U.S., 2005 - 2005
    • Figure 3-2: Psoriasis Patient Population by Disease Severity, U.S., 2005 - 2015
    • Figure 3-3: Diagnosis Rates by Psoriasis Severity, U.S., 2005 - 2015
    • Figure 3-4: Psoriasis Severity Treatment Rates, U.S., 2005 - 2015
    • Figure 3-5: Number of Treatments per Patient by Psoriasis Severity, U.S., 2005 -2015
    • Figure 3-6: Psoriasis Treatment Utilization Frequency, U.S., 2005 - 2015
    • Figure 3-7: Psoriasis Treatment Annual Prices by Treatment Type, U.S., 2005 -2015
    • Figure 3-8: Psoriasis Treatment Monthly Prices by Treatment Type, U.S., 2005 -2015
    • Figure 3-9: Total Market for Psoriasis Treatments, U.S., 2005 - 2015
    • Figure 3-10: Total Market for Psoriasis Treatments by Treatment Type, U.S.,2005 - 2015
    • Figure 3-11: Market for Topical Psoriasis Treatments, U.S., 2005 - 2015
    • Figure 3-12: Market for Topical Psoriasis Treatments by Treatment Type, U.S.,2005 - 2015
    • Figure 3-13: Market for Biologic Psoriasis Treatments, U.S., 2005 - 2015
    • Figure 3-14: Market for Non-Biologic Systemic Psoriasis Treatments, U.S., 2005- 2015
    • Figure 3-15: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2005 - 2015
    • Figure 3-16: Drivers and Limiters, Psoriasis Market, U.S., 2008
    • Figure 3-17: Leading Competitors in The Total Psoriasis Treatment Market, U.S.,2008
    • Figure 3-18: Leading Competitors in The Prescription Topical Psoriasis Treatment Market, U.S., 2008
    • Figure 3-19: Leading Competitors in The Biologic Psoriasis Treatment Market,U.S., 2008
    • Figure 3-20: Leading Competitors in The Non-Biologic Systemic Psoriasis Treatment Market, U.S., 2008
  • Abbreviations
• List of Charts
  • Executive Summary
    • Chart 1-1: Anti-Adhesion Product Market, U.S., 2005 - 2015
    • Chart 1-2: Psoriasis Treatment Utilization, U.S., 2008
    • Chart 1-3: Leading Competitors in The Psoriasis Treatment Market, U.S., 2008
  • Research Methodology
  • Psoriasis Cream and Medication Market
    • Chart 3-1: Psoriasis Patient Population by Disease Severity, U.S., 2008
    • Chart 3-2: Psoriasis Patient Population by Disease Severity, U.S., 2005 - 2015
    • Chart 3-3: Number of Treatments per Patient by Psoriasis Severity, U.S., 2005 -2015
    • Chart 3-4: Psoriasis Treatment Utilization Frequency, U.S., 2008
    • Chart 3-5: Psoriasis Treatment Utilization Frequency, U.S., 2015
    • Chart 3-6: Psoriasis Treatment Annual Prices by Treatment Type, U.S., 2008
    • Chart 3-7: Total Market for Psoriasis Treatments, U.S., 2005 - 2015
    • Chart 3-8: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2008(US$ Millions)
    • Chart 3-9: Total Market for Psoriasis Treatments by Treatment Type, U.S., 2015(US$ Millions)
    • Chart 3-10: Market for Topical Psoriasis Treatments, U.S., 2005 - 2015
    • Chart 3-11: Market for Topical Psoriasis Treatments by Treatment Type, U.S.,2008 (US$ Millions)
    • Chart 3-12: Market for Topical Psoriasis Treatments by Treatment Type, U.S.,2015 (US$ Millions)
    • Chart 3-13: Market for Biologic Psoriasis Treatments, U.S., 2005 - 2015
    • Chart 3-14: Market for Non-Biologic Systemic Psoriasis Treatments, U.S., 2005- 2015
    • Chart 3-15: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2008
    • Chart 3-16: Market for Non-Biologic Systemic Psoriasis Treatments by Treatment Type, U.S., 2015 (US$ Millions)
    • Chart 3-17: Leading Competitors in The Total Psoriasis Treatment Market, U.S.,2008
    • Chart 3-18: Leading Competitors in The Prescription Topical Psoriasis Treatment Market, U.S., 2008
    • Chart 3-19: Leading Competitors in The Biologic Psoriasis Treatment Market,U.S., 2008
    • Chart 3-20: Leading Competitors in The Non-Biologic Systemic Psoriasis Treatment Market, U.S., 2008
  • Abbreviations